home / stock / kala / kala news

KALA News and Press, Kala Pharmaceuticals Inc. From 03/29/23

Stock Information
Company Name: Kala Pharmaceuticals Inc.
Stock Symbol: KALA
Market: NASDAQ
Website: kalarx.com
Menu
KALA KALA Quote KALA Short KALA News KALA Articles KALA Message Board
Get KALA Alerts

News, Short Squeeze, Breakout and More Instantly...
KALA - Kala Pharmaceuticals Appoints Dr. Francis Mah as Chief Medical Advisor

ARLINGTON, Mass., March 29, 2023 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today announced the appointment o...
KALA - Kala Pharmaceuticals Announces Positive Safety Update from Cohort 1 of CHASE Phase 2b Clinical Trial Evaluating KPI-012 in Patients with PCED

--No safety issues identified in Cohort 1 -- -- Now proceeding to Cohort 2 to evaluate the safety and efficacy of two doses of KPI-012 in a multicenter, randomized, double-masked, vehicle-controlled trial -- -- Topline data for Cohort 2 targeted for 1Q 2024; if positive, trial could p...

KALA - Kala Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference

ARLINGTON, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today announced that it will pres...

KALA - Woodside Energy, New Oriental Education & Technology, Weibo among premarket losers' pack

2023-03-08 08:46:06 ET Intelligent Bio Solutions ( INBS ) -48% on proposed public offering . Castor Maritime ( CTRM ) -36% . Miromatrix Medical ( MIRO ) -32% on pricing $10M stock offering . United Natural Foods ( UNFI ) -22% on Q2...
KALA - KALA and NVOS among healthcare movers

2023-03-07 11:28:43 ET Gainers: Unicycive ( UNCY ) +52% . Bionomics ( BNOX ) +49% . Novo Integrated Sciences ( NVOS ) +37% . Protagonist Therapeutics ( PTGX ) +34% . Allakos ( ALLK ) +22% . Losers: Cara ( CARA ) -28...

KALA - GOL, RCON and ENTX among mid-day movers

2023-03-06 13:05:55 ET Gainers: Bellerophon ( BLPH ) +86% . Ambrx Biopharma ( AMAM ) +69% . BridgeBio Pharma ( BBIO ) +56% . Avalon GloboCare ( ALBT ) +47% . Azul ( AZUL ) +42% . TCR2 Therapeutics ( TCRR ) +38% . ...

KALA - Kala jumps 26% to extend gains after Q4 2022 update

2023-03-06 10:32:51 ET Following a ~65% rise in the previous session, clinical-stage biotech Kala Pharmaceuticals ( NASDAQ: KALA ) added another ~26% i n the morning hours Monday as Wall Street reacted to the company’s Q4 2022 results. Highlights of the financials...
KALA - BridgeBio, Armata top healthcare gainers; Aclaris, Adaptimmune among losers

2023-03-06 10:00:19 ET Gainers: BridgeBio Pharma ( BBIO ) +67% . Armata Pharmaceuticals ( ARMP ) +23% . TCR2 Therapeutics ( TCRR ) +21% . Euda Health ( EUDA ) +12% . Kala Pharmaceuticals ( KALA ) +16% . Losers: Aclaris...

KALA - KALA, AZUL and GOL are among pre market gainers

2023-03-06 08:32:34 ET BridgeBio Pharma ( BBIO ) +57% Announces Positive Phase 2 Cohort 5 Results of Infigratinib in Achondroplasia Demonstrating Mean Increase in Annualized Height Velocity of 3.03 cm/year with No Treatment-related Adverse Events. TCR2 Therapeutics ...

KALA - Kala Pharmaceuticals GAAP EPS of -$7.97 misses by $1.42

Kala Pharmaceuticals press release ( NASDAQ: KALA ): Q4 GAAP EPS of -$7.97 misses by $1.42 . As of December 31, 2022, Kala had cash and cash equivalents of $70.5 million, compared to $52.4 million as of September 30, 2022. Based on its current plans, Kala anticipates that ...
Previous 10 Next 10